Notice of Proposals To Engage in or To Acquire Companies Engaged in Permissible Nonbanking Activities, 20606 [2017-08854]

Download as PDF 20606 Federal Register / Vol. 82, No. 84 / Wednesday, May 3, 2017 / Notices 1. Piedmont Bancorp, Inc., Norcross, Georgia; to merge with Mountain Valley Bancshares, Inc., and thereby indirectly acquire, Mountain Valley Community Bank, both of Cleveland, Georgia. B. Federal Reserve Bank of Chicago (Colette A. Fried, Assistant Vice President), 230 South LaSalle Street, Chicago, Illinois 60690–1414: 1. West Town Bancorp, Inc., Raleigh, North Carolina; to acquire 100 percent of the outstanding voting shares of Sound Banking Company, Morehead City, North Carolina. Board of Governors of the Federal Reserve System, April 27, 2017. Yao-Chin Chao, Assistant Secretary of the Board. [FR Doc. 2017–08890 Filed 5–2–17; 8:45 am] Trust Company, LLC. Plimoth Massachusetts, and thereby engage in trust company activities pursuant to section 225.28(b)(5). In addition, Plimoth has applied to acquire certain assets and assume certain liabilities from Savings Institute Bank and Trust Company, Willimantic, Connecticut. Dated: April 27, 2017. Frank Hearl, Chief of Staff, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention. Board of Governors of the Federal Reserve System, April 27, 2017. Yao-Chin Chao, Assistant Secretary of the Board. DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2017–08854 Filed 5–2–17; 8:45 am] BILLING CODE 6210–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 6210–01–P Centers for Disease Control and Prevention FEDERAL RESERVE SYSTEM [CDC–2015–0021; Docket Number NIOSH– 153–C] nlaroche on DSK30NT082PROD with NOTICES Notice of Proposals To Engage in or To Acquire Companies Engaged in Permissible Nonbanking Activities The companies listed in this notice have given notice under section 4 of the Bank Holding Company Act (12 U.S.C. 1843) (BHC Act) and Regulation Y, (12 CFR part 225) to engage de novo, or to acquire or control voting securities or assets of a company, including the companies listed below, that engages either directly or through a subsidiary or other company, in a nonbanking activity that is listed in § 225.28 of Regulation Y (12 CFR 225.28) or that the Board has determined by Order to be closely related to banking and permissible for bank holding companies. Unless otherwise noted, these activities will be conducted throughout the United States. Each notice is available for inspection at the Federal Reserve Bank indicated. The notice also will be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the question whether the proposal complies with the standards of section 4 of the BHC Act. Unless otherwise noted, comments regarding the applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than May 17, 2017. A. Federal Reserve Bank of Boston (Prabal Chakrabarti, Senior Vice President) 600 Atlantic Avenue, Boston, Massachusetts 02210–2204. Comments can also be sent electronically to BOS.SRC.Applications.Comments@ bos.frb.org: 1. Narragansett Financial Corp., Swansea, Massachusetts; to retain 80 percent of the voting shares of Plimoth VerDate Sep<11>2014 14:29 May 02, 2017 Jkt 241001 Issuance of Final Guidance Publications National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of issuance of final guidance publications. AGENCY: NIOSH announces the availability of the following final 5 Skin Notation Profiles: Acrylic acid [CAS No. 79–01–7], Dichlorvos [CAS No. 62–73– 7], Morpholine [CAS No. 110–91–8], Ethyl p-nitrophenyl phenylphosphorothioate (EPN) [CAS No. 2104–64–5], Dioxathion [CAS No. 78–34–2]. DATES: The final Skin Notation Profiles documents were published on April 10, 2017. ADDRESSES: These documents may be obtained at the following link: http:// www.cdc.gov/niosh/topics/skin/skinnotation_profiles.html. FOR FURTHER INFORMATION CONTACT: Naomi Hudson, Dr. P.H., NIOSH, Education and Information Division (EID), Robert A. Taft Laboratories, 1090 Tusculum Ave. MS–C32, Cincinnati, OH 45226, email: iuz8@cdc.gov. SUPPLEMENTARY INFORMATION: On May 1, 2015, NIOSH published a request for public review in the Federal Register [80 FR 24932] on skin notation profiles and technical documents. All comments received were reviewed and accepted where appropriate. SUMMARY: PO 00000 Frm 00048 Fmt 4703 Sfmt 9990 [FR Doc. 2017–08887 Filed 5–2–17; 8:45 am] BILLING CODE 4163–19–P National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Peer Review Meeting. Date: June 1, 2017. Time: 2:00 p.m. to 5:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, Room 3F40, 5601 Fishers Lane, Rockville, MD 20892 (Telephone Conference Call). Contact Person: Robert C. Unfer, Ph.D., Scientific Review Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, 5601 Fishers Lane, Room 3F40 MSC 9823, Rockville, MD 20892–9823, 240–669–5035, unferrc@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: April 28, 2017. Natasha M. Copeland, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2017–08946 Filed 5–2–17; 8:45 am] BILLING CODE 4140–01–P E:\FR\FM\03MYN1.SGM 03MYN1

Agencies

[Federal Register Volume 82, Number 84 (Wednesday, May 3, 2017)]
[Notices]
[Page 20606]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-08854]


-----------------------------------------------------------------------

FEDERAL RESERVE SYSTEM


Notice of Proposals To Engage in or To Acquire Companies Engaged 
in Permissible Nonbanking Activities

    The companies listed in this notice have given notice under section 
4 of the Bank Holding Company Act (12 U.S.C. 1843) (BHC Act) and 
Regulation Y, (12 CFR part 225) to engage de novo, or to acquire or 
control voting securities or assets of a company, including the 
companies listed below, that engages either directly or through a 
subsidiary or other company, in a nonbanking activity that is listed in 
Sec.  225.28 of Regulation Y (12 CFR 225.28) or that the Board has 
determined by Order to be closely related to banking and permissible 
for bank holding companies. Unless otherwise noted, these activities 
will be conducted throughout the United States.
    Each notice is available for inspection at the Federal Reserve Bank 
indicated. The notice also will be available for inspection at the 
offices of the Board of Governors. Interested persons may express their 
views in writing on the question whether the proposal complies with the 
standards of section 4 of the BHC Act.
    Unless otherwise noted, comments regarding the applications must be 
received at the Reserve Bank indicated or the offices of the Board of 
Governors not later than May 17, 2017.
    A. Federal Reserve Bank of Boston (Prabal Chakrabarti, Senior Vice 
President) 600 Atlantic Avenue, Boston, Massachusetts 02210-2204. 
Comments can also be sent electronically to 
BOS.SRC.Applications.Comments@bos.frb.org:
    1. Narragansett Financial Corp., Swansea, Massachusetts; to retain 
80 percent of the voting shares of Plimoth Trust Company, LLC. Plimoth 
Massachusetts, and thereby engage in trust company activities pursuant 
to section 225.28(b)(5).
    In addition, Plimoth has applied to acquire certain assets and 
assume certain liabilities from Savings Institute Bank and Trust 
Company, Willimantic, Connecticut.

    Board of Governors of the Federal Reserve System, April 27, 
2017.
Yao-Chin Chao,
Assistant Secretary of the Board.
[FR Doc. 2017-08854 Filed 5-2-17; 8:45 am]
 BILLING CODE 6210-01-P